[
  {
    "ts": "2025-09-17T22:00:03+00:00",
    "headline": "Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note",
    "summary": "Gilead Sciences (GILD) reached $112.26 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-gild-ascends-while-220003189.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "45fb2d1e-06e6-39dd-b718-7f88d663cfc4",
      "content": {
        "id": "45fb2d1e-06e6-39dd-b718-7f88d663cfc4",
        "contentType": "STORY",
        "title": "Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note",
        "description": "",
        "summary": "Gilead Sciences (GILD) reached $112.26 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.",
        "pubDate": "2025-09-17T22:00:03Z",
        "displayTime": "2025-09-17T22:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5VYVrk.dAWOtAbYePjBVnw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bx6KQdkgJ6y2nL6XqljE4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-ascends-while-220003189.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-ascends-while-220003189.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-17T11:00:00+00:00",
    "headline": "Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis",
    "summary": "Data support advancement of GS-6791 into clinical testing in patients with inflammatory diseases; first-in-human Phase 1 trial in healthy volunteers is ongoing Data are being presented at the European Academy of Dermatology and Venereology (EADV) Congress SAN FRANCISCO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the presentation of preclinical data from GS-6791/NX-0479, a novel IRAK4 protein degrader discovered as part of the company’s ongoing rese",
    "url": "https://finance.yahoo.com/news/nurix-therapeutics-presents-preclinical-data-110000675.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "17ffec51-7bf6-34ed-ba40-5cad2938fc4f",
      "content": {
        "id": "17ffec51-7bf6-34ed-ba40-5cad2938fc4f",
        "contentType": "STORY",
        "title": "Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis",
        "description": "",
        "summary": "Data support advancement of GS-6791 into clinical testing in patients with inflammatory diseases; first-in-human Phase 1 trial in healthy volunteers is ongoing Data are being presented at the European Academy of Dermatology and Venereology (EADV) Congress SAN FRANCISCO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the presentation of preclinical data from GS-6791/NX-0479, a novel IRAK4 protein degrader discovered as part of the company’s ongoing rese",
        "pubDate": "2025-09-17T11:00:00Z",
        "displayTime": "2025-09-17T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2bac359058f8ba3c51bd304c2eb375c0",
          "originalWidth": 124,
          "originalHeight": 59,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Bo1Kaht6Lnbt9HxUs8UQiw--~B/aD01OTt3PTEyNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2bac359058f8ba3c51bd304c2eb375c0.cf.webp",
              "width": 124,
              "height": 59,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d4ApEsx4wkV_auIuBRdN4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2bac359058f8ba3c51bd304c2eb375c0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nurix-therapeutics-presents-preclinical-data-110000675.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nurix-therapeutics-presents-preclinical-data-110000675.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NRIX"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]